Presentation and management of diverse cutaneous reactions after cyclin-dependent kinase 4/6 inhibitor use
Amigo M, Hoffman K, Chung C, Lustberg M, Wesolowski R, VanDeusen J, Stover D, Suarez GT, Cherian M, Kaffenberger B, Dulmage B. Presentation and management of diverse cutaneous reactions after cyclin-dependent kinase 4/6 inhibitor use. Journal Of The American Academy Of Dermatology 2021, 86: 1346-1348. PMID: 33961922, DOI: 10.1016/j.jaad.2021.04.092.Peer-Reviewed Original ResearchCell Cycle ProteinsCyclin-Dependent Kinase 4Cyclin-Dependent Kinase Inhibitor p16Enzyme InhibitorsHumans